Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Sm14+GLA-SE Recombinant Vaccine Against <i>Schistosoma mansoni</i> and <i>S. haematobium</i> in Adults and School Children: Phase II Clinical Trials in West Africa.

Vaccines·2025
Same author

Editorial: Antiviral options for emerging and reemerging viral diseases: current therapeutics, novel drug candidates and new approaches.

Frontiers in cellular and infection microbiology·2024
Same author

Antiviral options and therapeutics against influenza: history, latest developments and future prospects.

Frontiers in cellular and infection microbiology·2023
Same author

Clinical and Diagnostic Findings of Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy in the COVID-19 Era.

Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde·2023
Same author

PI3K/Akt/Nrf2 mediated cellular signaling and virus-host interactions: latest updates on the potential therapeutic management of SARS-CoV-2 infection.

Frontiers in molecular biosciences·2023
Same author

A review of COVID-19 vaccines in development: 6 months into the pandemic.

The Pan African medical journal·2021

Related Experiment Video

Updated: Mar 15, 2026

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

21.6K

Zika: what we know and don't know.

Doudou Diop1, Dirga Sakti Rambe2, Melvin Sanicas3

  • 1EPLS Biomedical Research Center, Saint-Louis, Senegal.

The Pan African Medical Journal
|September 2, 2016
PubMed
Summary

Zika virus, linked to microcephaly, is a growing global concern spread by mosquitoes. Research is accelerating vaccine development, aiming to shorten the typical decade-long process.

Keywords:
Zikadiseasepreventiontreatmentvirus

More Related Videos

Modelling Zika Virus Infection of the Developing Human Brain In Vitro Using Stem Cell Derived Cerebral Organoids
09:18

Modelling Zika Virus Infection of the Developing Human Brain In Vitro Using Stem Cell Derived Cerebral Organoids

Published on: September 19, 2017

11.1K
Vector Competence Analyses on Aedes aegypti Mosquitoes using Zika Virus
10:35

Vector Competence Analyses on Aedes aegypti Mosquitoes using Zika Virus

Published on: May 31, 2020

3.6K

Related Experiment Videos

Last Updated: Mar 15, 2026

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

21.6K
Modelling Zika Virus Infection of the Developing Human Brain In Vitro Using Stem Cell Derived Cerebral Organoids
09:18

Modelling Zika Virus Infection of the Developing Human Brain In Vitro Using Stem Cell Derived Cerebral Organoids

Published on: September 19, 2017

11.1K
Vector Competence Analyses on Aedes aegypti Mosquitoes using Zika Virus
10:35

Vector Competence Analyses on Aedes aegypti Mosquitoes using Zika Virus

Published on: May 31, 2020

3.6K

Area of Science:

  • Virology
  • Epidemiology
  • Public Health

Background:

  • The Zika virus gained prominence following reports linking it to microcephaly.
  • Rapid transmission via mosquito bites has led to widespread global concern.
  • Currently, no vaccine is available to prevent Zika virus infection.

Purpose of the Study:

  • To summarize the current understanding of Zika virus and its public health impact.
  • To highlight the urgent need for vaccine development.
  • To underscore the global scientific mobilization in response to the Zika outbreak.

Main Methods:

  • Literature review of recent Zika virus research.
  • Analysis of epidemiological data on Zika virus spread.
  • Assessment of vaccine development pipelines and progress.

Main Results:

  • Zika virus transmission is primarily through mosquito vectors.
  • The virus poses a significant public health threat, particularly due to its association with microcephaly.
  • Accelerated vaccine development efforts are underway globally.

Conclusions:

  • The rapid global response to Zika virus underscores its severity.
  • Expedited vaccine development is crucial to mitigate future outbreaks.
  • Continued research is essential for comprehensive Zika virus control.